1.
Gordon K, Foley P, Krueger J, Pinter A, Reich K, Vender R, Vanvoorden V, Madden C, Peterson L, Blauvelt A. Efficacy and Safety of Bimekizumab in Patients with Moderate to Severe Plaque Psoriasis: Results from BE READY, a 56-Week Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study with Randomized Withdrawal. J of Skin [Internet]. 2020Oct.27 [cited 2022May17];4(6):s83. Available from: https://www.jofskin.org/index.php/skin/article/view/1116